|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
109,840,000 |
Market
Cap: |
114.23(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.821 - $2 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile OptiNose is a pharmaceutical company focused on the development and commercialization of products for patients treated by ear, nose and throat and allergy specialists. Co.'s commercial product, XHANCE® (fluticasone propionate) nasal spray is a therapeutic utilizing its proprietary Exhalation Delivery System (EDS®) for the treatment of chronic rhinosinusitis with nasal polyps and. Co.'s solutions also include EDS, which enables the development of drug-device combination products intended for self-administration. Co. has developed both a liquid delivery EDS and a powder delivery EDS utilizing natural functional behaviors of the upper nasal airways intended to provide drug deposition.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
36,602 |
105,596 |
121,670 |
401,656 |
Total Sell Value |
$68,812 |
$156,615 |
$178,637 |
$979,259 |
Total People Sold |
3 |
3 |
3 |
6 |
Total Sell Transactions |
3 |
6 |
8 |
33 |
End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Marino Michael F Iii |
Chief Legal Officer & Corp Sec |
|
2021-12-16 |
4 |
S |
$1.64 |
$951 |
D/D |
(580) |
97,432 |
|
-41% |
|
Goldan Keith A. |
Chief Financial Officer |
|
2021-12-16 |
4 |
S |
$1.64 |
$951 |
D/D |
(580) |
89,613 |
|
-41% |
|
Miller Peter K |
Chief Executive Officer |
|
2021-12-16 |
4 |
S |
$1.64 |
$6,189 |
D/D |
(3,774) |
691,300 |
|
-41% |
|
Mahmoud Ramy A |
President and COO |
|
2021-12-16 |
4 |
S |
$1.64 |
$1,502 |
D/D |
(916) |
280,849 |
|
-41% |
|
Clavelli Victor M |
Chief Commercial Officer |
|
2021-12-16 |
4 |
S |
$1.64 |
$2,060 |
D/D |
(1,256) |
138,668 |
|
-41% |
|
Dempsey Kyle |
Director |
|
2021-12-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
9,375 |
|
36% |
|
Bednarski Eric |
Director |
|
2021-12-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
63,344 |
|
36% |
|
Mahmoud Ramy A |
President and COO |
|
2021-09-16 |
4 |
S |
$2.79 |
$34,860 |
D/D |
(12,499) |
281,765 |
|
23% |
|
Goldan Keith A. |
Chief Financial Officer |
|
2021-09-16 |
4 |
S |
$2.79 |
$1,612 |
D/D |
(578) |
90,193 |
|
23% |
|
Marino Michael F Iii |
Chief Legal Officer & Corp Sec |
|
2021-09-16 |
4 |
S |
$2.79 |
$1,612 |
D/D |
(578) |
98,012 |
|
23% |
|
Clavelli Victor M |
Chief Commercial Officer |
|
2021-09-15 |
4 |
D |
$2.79 |
$3,278 |
D/D |
(1,177) |
139,924 |
|
- |
|
Miller Peter K |
Chief Executive Officer |
|
2021-09-15 |
4 |
D |
$2.79 |
$67,222 |
D/D |
(24,137) |
696,074 |
|
- |
|
Miller Peter K |
Chief Executive Officer |
|
2021-09-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
79,508 |
720,211 |
|
- |
|
Mahmoud Ramy A |
President and COO |
|
2021-09-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
39,754 |
294,264 |
|
- |
|
Marino Michael F Iii |
Chief Legal Officer & Corp Sec |
|
2021-06-17 |
4 |
S |
$3.73 |
$2,148 |
D/D |
(576) |
98,590 |
|
24% |
|
Goldan Keith A. |
Chief Financial Officer |
|
2021-06-17 |
4 |
S |
$3.73 |
$2,148 |
D/D |
(576) |
90,771 |
|
24% |
|
Mahmoud Ramy A |
President and COO |
|
2021-06-17 |
4 |
S |
$3.73 |
$3,391 |
D/D |
(909) |
254,510 |
|
24% |
|
Clavelli Victor M |
Chief Commercial Officer |
|
2021-06-15 |
4 |
D |
$3.75 |
$4,414 |
D/D |
(1,177) |
141,101 |
|
- |
|
Miller Peter K |
Chief Executive Officer |
|
2021-06-15 |
4 |
D |
$3.75 |
$8,588 |
D/D |
(2,290) |
634,665 |
|
- |
|
Clavelli Victor M |
Chief Commercial Officer |
|
2021-05-20 |
4 |
B |
$3.06 |
$104,040 |
D/D |
34,000 |
142,278 |
2.74 |
-3% |
|
Scodari Joseph C |
Director |
|
2021-05-10 |
4 |
B |
$2.99 |
$29,900 |
D/D |
10,000 |
31,230 |
2.39 |
-3% |
|
Miller Peter K |
Chief Executive Officer |
|
2021-03-18 |
4 |
B |
$3.91 |
$45,853 |
D/D |
11,742 |
636,955 |
2.81 |
-29% |
|
Miller Peter K |
Chief Executive Officer |
|
2021-03-17 |
4 |
B |
$3.85 |
$3,029 |
D/D |
787 |
625,213 |
2.73 |
-33% |
|
Clavelli Victor M |
Chief Commercial Officer |
|
2021-03-15 |
4 |
S |
$3.92 |
$19,816 |
D/D |
(5,055) |
108,278 |
|
28% |
|
Miller Peter K |
Chief Executive Officer |
|
2021-03-15 |
4 |
S |
$3.92 |
$38,004 |
D/D |
(9,695) |
624,426 |
|
28% |
|
270 Records found
|
|
Page 4 of 11 |
|
|